These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Electroencephalographic activation by fluoxetine in rats: role of 5-HT(1A) receptors and enhancement of concurrent acetylcholinesterase inhibitor treatment. Dringenberg HC; Diavolitsis P Neuropharmacology; 2002 Feb; 42(2):154-61. PubMed ID: 11804611 [TBL] [Abstract][Full Text] [Related]
7. Potentiation by DSP-4 of EEG slowing and memory impairment in basal forebrain-lesioned rats. Abe K; Horiuchi M; Yoshimura K Eur J Pharmacol; 1997 Feb; 321(2):149-55. PubMed ID: 9063682 [TBL] [Abstract][Full Text] [Related]
8. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats. Diez-Ariza M; Redondo C; García-Alloza M; Lasheras B; Del Río J; Ramírez MJ Psychopharmacology (Berl); 2003 Aug; 169(1):35-41. PubMed ID: 12845416 [TBL] [Abstract][Full Text] [Related]
9. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Bejar C; Wang RH; Weinstock M Eur J Pharmacol; 1999 Nov; 383(3):231-40. PubMed ID: 10594314 [TBL] [Abstract][Full Text] [Related]
10. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists. Dringenberg HC; Zalan RM Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009 [TBL] [Abstract][Full Text] [Related]
11. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats. Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626 [TBL] [Abstract][Full Text] [Related]
13. Influence of cholinesterase inhibitors on cortical slow-wave activity in aging nonhuman primate. Fitten LJ; Perryman KM; O'Neill J; Halgren E Pharmacol Biochem Behav; 1994 Sep; 49(1):235-9. PubMed ID: 7816881 [TBL] [Abstract][Full Text] [Related]
14. The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing. Riekkinen P; Jäkälä P; Sirviö J; Koivisto E; Miettinen R; Riekkinen P Brain Res Bull; 1991 Apr; 26(4):633-7. PubMed ID: 1868362 [TBL] [Abstract][Full Text] [Related]
15. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment? Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. Wang H; Carlier PR; Ho WL; Lee NT; Pang YP; Han YF Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):211-7. PubMed ID: 10452094 [TBL] [Abstract][Full Text] [Related]
17. Effects of selegiline alone or with donepezil on memory impairment in rats. Takahata K; Minami A; Kusumoto H; Shimazu S; Yoneda F Eur J Pharmacol; 2005 Aug; 518(2-3):140-4. PubMed ID: 16061218 [TBL] [Abstract][Full Text] [Related]
18. A novel anticholinesterase THB013: biochemical and behavioural studies. Adem A; Mohammed AH; Winblad B; Henriksson BE J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):139-48. PubMed ID: 7893376 [TBL] [Abstract][Full Text] [Related]
19. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice. Chen H; Xiang S; Huang L; Lin J; Hu S; Mak SH; Wang C; Wang Q; Cui W; Han Y Metab Brain Dis; 2018 Aug; 33(4):1131-1139. PubMed ID: 29564727 [TBL] [Abstract][Full Text] [Related]
20. Effects of combined nimodipine and metrifonate on rat cognition and cortical EEG. Jäkälä P; Riekkinen M; Björklund M; Koivisto E; Schmidt B; Riekkinen P Eur J Pharmacol; 1996 Dec; 318(2-3):239-50. PubMed ID: 9016911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]